Sovereign Immunity (FSIA)
OBB Personenverkehr AG v. Sachs, 136 S. Ct. 390 (2015) (Supreme Court of the United States)
Study notes for OBB Personenverkehr AG v. Sachs: professor notes, cold call prep, exam angles, and memory aids.
A personal injury suit against a foreign state-owned entity is not 'based upon' U.S. commercial activity if the injury-causing conduct occurred abroad.
This case primarily addresses the commercial activity exception under the Foreign Sovereign Immunities Act (FSIA), specifically how it applies in the context of international personal injury claims. Professors are likely to emphasize the importance of establishing a direct link between the plaintiff's claim and the commercial activities conducted by the foreign entity within the United States. The Court focused on the need for the 'gravamen'—the essence or foundation of the claim—to arise clearly from U.S. activities to bypass sovereign immunity. Moreover, the Court’s analysis underscores the distinction between commercial activities and tortious acts occurring outside U.S. territory, which is crucial for understanding FSIA implications in international law.
Additionally, the ruling illustrates the challenges plaintiffs face when foreign entities are involved, particularly when injuries arise from actions taken in their home countries as opposed to the U.S. context, reinforcing the principles of sovereign immunity while emphasizing jurisdictional boundaries.
C.A.R.E. (Commercial Activity Required to Establish Exception)
| Case | Distinction |
|---|---|
| Taylor v. United States | Taylor involved a direct transaction between the plaintiff and the government entity within U.S. borders, unlike the pass purchase in Sachs, which was through an intermediary. |
| Hertz Corp. v. Friend | Hertz centered on the corporate presence within the U.S. rather than foreign sovereign immunity, making it less applicable in matters of international tort claims. |
Upholding sovereign immunity encourages international cooperation and respects foreign governments' autonomy, which is vital in a globalized world.
Denying access to U.S. courts for legitimate claims against foreign state-owned entities may inhibit justice for injured parties and can undermine consumer protections.
This case may be tested on the interpretation and application of the commercial-activity exception under FSIA, specifically emphasizing how the location of injury impacts a foreign entity's claim to sovereign immunity.